Cellectar Biosciences, Inc. Increase (Decrease) in Other Operating Assets and Liabilities, Net
Cellectar Biosciences, Inc. (CLRB) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $220.16 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2018-11-13
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-09-30 was $40.44K, a 2853.83% increase year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-06-30 was $129.74K, a 10569.41% increase year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-03-31 was $49.98K, a 4010.20% increase year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2017-09-30 was $1.37K, a 77.82% decline year-over-year.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month |
|---|---|---|---|
| 2018-09-30 | $40.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $170.18K derived: sum of 2 quarters · filed 2018-11-13 | $220.16K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $129.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $179.72K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $49.98K 10-Q · filed 2018-05-11 | ||
| 2017-09-30 | $1.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $2.58K derived: sum of 2 quarters · filed 2018-11-13 | $3.80K 10-Q · filed 2018-11-13 |
| 2017-06-30 | $1.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $2.43K 10-Q · filed 2018-08-10 | |
| 2017-03-31 | $1.22K 10-Q · filed 2018-05-11 | ||
| 2016-09-30 | $6.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.50K derived: sum of 2 quarters · filed 2017-11-09 | $6.82K 10-Q · filed 2017-11-09 |
| 2016-06-30 | $326.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $651.00 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $325.00 10-Q · filed 2017-05-11 | ||
| 2015-09-30 | -$396.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$936.00 derived: sum of 2 quarters · filed 2016-11-10 | -$1.48K 10-Q · filed 2016-11-10 |
| 2015-06-30 | -$540.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$1.08K 10-Q · filed 2016-08-11 | |
| 2015-03-31 | -$539.00 10-Q · filed 2016-05-12 | ||
| 2014-09-30 | -$1.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$2.62K derived: sum of 2 quarters · filed 2015-11-12 | -$4.00K 10-Q · filed 2015-11-12 |
| 2014-06-30 | -$1.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$2.62K 10-Q · filed 2015-08-12 | |
| 2014-03-31 | -$1.38K 10-Q · filed 2015-05-20 | ||
| 2013-09-30 | -$2.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | -$6.45K 10-Q · filed 2015-05-20 | |
| 2013-06-30 | -$4.39K 10-Q · filed 2014-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |